News
Are Gene Therapy Stocks The Market's Next Big Winners?
It’s not often that you see a company whose main product comes with a price tag of over $2 million, but that’s the case with biotechs BioMarin Pharmaceutical (NASDAQ: BMRN) and Sarepta
Argenx's 28% Surge & Promising Product Propel Investor Confidence
If you want to get an isolated view of a constructive base taking shape in a strong stock, take a look at the Argenix SE (NASDAQ: ARGX) chart.
The stock gapped up nearly 28% on July 17, after
Flee to Healthcare Stocks if Recession Rears its Head?
If you’re looking for a sector that’s on sale, look to healthcare. The Health Care Select Sector SPDR Fund (NYSEARCA: XLV) is down 2.50% in the past month, lagging the S&P 500.
The top
Flee to Healthcare Stocks if Recession Rears its Head?
If you’re looking for a sector that’s on sale, look to healthcare. The Health Care Select Sector SPDR Fund (NYSEARCA: XLV) is down 2.50% in the past month, lagging the S&P 500.
The top
Could Ely Lilly Be the Best Pharma Stock to Own Now and Forever?
Pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) stock has been on a tear, trading up 57.7% year-to-date (YTD). The company is firing on all cylinders with its leading medications and a highly
Can These 3 Healthcare Dividend Stocks Deliver Income Growth?
The healthcare industry presents a fertile shopping ground for undervalued dividend stocks. S&P 500 components Pfizer Inc. (NYSE: PFE), Medtronic plc (NYSE: MDT) and Gilead Sciences Inc. (NASDAQ:
Can These 3 Healthcare Dividend Stocks Deliver Income Growth?
The healthcare industry presents a fertile shopping ground for undervalued dividend stocks. S&P 500 components Pfizer Inc. (NYSE: PFE), Medtronic plc (NYSE: MDT) and Gilead Sciences Inc. (NASDAQ:
High Yield, Low Beta Stocks to Buy for the Next Market Meltdown
The market's fear indicator, the VIX index, is bobbing along at long-term lows and gives little indication of a looming correction, but investors should assume one is brewing. The index is down at
Insiders Are Buying These 2 Stocks
Understanding insider buying is crucial for savvy investors looking to make informed decisions in the stock market. Insider buying occurs when company insiders, such as executives or directors,
2 Stocks That Doubled EPS Estimates and Flashing Buy Signals
The second quarter of the 2023 earnings season has drawn to a close. There were many surprises in every sector. However, there were some standout surprises with upcoming catalysts to watch. These
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
Major pharmaceutical companies including Johnson & Johnson (NYSE: JNJ), Novartis AG (NYSE: NVS), Bristol-Myers Squibb (NYSE: BMY), Merck & Co., Inc. (NYSE: MRK), Eli Lilly & Co. (NYSE: LLY) and
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
Major pharmaceutical companies including Johnson & Johnson (NYSE: JNJ), Novartis AG (NYSE: NVS), Bristol-Myers Squibb (NYSE: BMY), Merck & Co., Inc. (NYSE: MRK), Eli Lilly & Co. (NYSE: LLY) and
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
Major pharmaceutical companies including Johnson & Johnson (NYSE: JNJ), Novartis AG (NYSE: NVS), Bristol-Myers Squibb (NYSE: BMY), Merck & Co., Inc. (NYSE: MRK), Eli Lilly & Co. (NYSE: LLY) and
3 Takeaways from the August Inflation Report
The market advanced following the August PCE price index report, but investors and traders should not discount the news. The PCE index remains cool relative to the peaks of the inflation scare,
A Significant Reversal is in Sight for These 5 Med Tech Companies
Med tech has been on the skids for no fault of its own. It’s not the industry's fault that price action was driven to a frothy bubble by COVID-inspired trading outlooks or that the market has
5 Good Reasons it's Time to Buy High-Yield Dividend King 3M
3M (NYSE: MMM) is an interesting speculation on high-yield dividend growth and value, and now is an excellent time to take a bite. The company is navigating a difficult time with aplomb, and the
Eilt: Biotech Hot Stock entwickelt Blockbuster - Hautkrebs vollständig geheilt. Jetzt 240% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Biotech Hot Stock entwickelt Blockbuster - Hautkrebs vollständig geheilt. 240% mit Biotech Aktientip nach 134.452%
25.08.23 08:02
London (www.aktiencheck.de, Anzeige)
Eilt: Biotech Hot Stock entwickelt Blockbuster - Hautkrebs vollständig geheilt. Jetzt 240% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Biotech Hot Stock entwickelt Blockbuster - Hautkrebs vollständig geheilt. 240% mit Biotech Aktientip nach 134.452%
25.08.23 08:02
London (www.aktiencheck.de, Anzeige)
Eilt: Biotech Hot Stock entwickelt Blockbuster - Hautkrebs vollständig geheilt. Jetzt 240% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Biotech Hot Stock entwickelt Blockbuster - Hautkrebs vollständig geheilt. 240% mit Biotech Aktientip nach 134.452%
25.08.23 08:02
London (www.aktiencheck.de, Anzeige)
Eilt: Hautkrebs vollständig geheilt - Biotech Hot Stock meldet Lizenzdeal mit Nr. 1. Jetzt 223% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - Biotech Hot Stock meldet Lizenzdeal mit Nr. 1. 223% mit Biotech-Aktie nach 15.973%
24.08.23 08:03
London (www.aktiencheck.de, Anzeige)
Eilt: Hautkrebs vollständig geheilt - Biotech Hot Stock meldet Lizenzdeal mit Nr. 1. Jetzt 223% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - Biotech Hot Stock meldet Lizenzdeal mit Nr. 1. 223% mit Biotech-Aktie nach 15.973%
24.08.23 08:03
London (www.aktiencheck.de, Anzeige)
Eilt: Hautkrebs vollständig geheilt - Biotech Hot Stock meldet Lizenzdeal mit Nr. 1. Jetzt 223% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - Biotech Hot Stock meldet Lizenzdeal mit Nr. 1. 223% mit Biotech-Aktie nach 15.973%
24.08.23 08:03
London (www.aktiencheck.de, Anzeige)
Disney's Big Breakup? Wall Street, Iger Ponder A Magical Split
For Walt Disney Co. (NYSE: DIS) shareholders, their brokerage statements haven’t exactly been the happiest place on earth. The stock has lagged the S&P 500 for the past 10 years, although it’s
2 Stocks that Historically Rise in the Fall
The start of school means that autumn is just around the corner. As temperatures drop, certain seasonal factors come into play in the country and specific industries. The stock market is a
2 Stocks that Historically Rise in the Fall
The start of school means that autumn is just around the corner. As temperatures drop, certain seasonal factors come into play in the country and specific industries. The stock market is a